Circulating microparticles from subjects with active pulmonary tuberculosis infection modulate immune response

Josimar Dornelas Moreira1,2, Fernanda Freire Campos Nunes1, Fernanda Cristina Gontijo Evangelista1

  • 1Department of Clinical and Toxicological Analysis, Pharmacy School, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Insights

Elevated microparticles (MPs) in active pulmonary tuberculosis patients influence immune cell cytokine production. These findings highlight MPs as potential biomarkers and therapeutic targets in tuberculosis research.

Area of Science:

  • Immunology
  • Hematology
  • Infectious Diseases

Background:

  • Microparticles (MPs) are small vesicles released from cell membranes.
  • Elevated circulating MPs are observed in various inflammatory and infectious conditions.
  • Pulmonary tuberculosis (TB) is a significant global health challenge.

Discussion:

  • Circulating MPs from active pulmonary TB patients exhibit immunomodulatory properties.
  • These MPs can alter cytokine production by immune cells in vitro.
  • This suggests a role for MPs in the host immune response to TB.

Key Insights:

  • Plasma MP levels are increased in active pulmonary TB.
  • MPs from TB patients affect immune cell cytokine profiles.
  • MPs represent a potential diagnostic or prognostic marker for TB.

Outlook:

  • Further research into MP function in TB pathogenesis is warranted.
  • Investigating MPs as therapeutic targets could offer new treatment strategies.
  • Exploring MP-based diagnostics for TB detection and monitoring is a promising avenue.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
874
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
502
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
323
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
286
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
605